Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This compound is an experimental small molecule belonging to the class of organic compounds known as 2-benzylaminopyridines, which are aromatic compounds containing a pyridine ring substituted at position two by a benzylamine group. It has been cataloged in chemical and structural databases (DrugBank DB07809, PDB ligand G44, ChemSpider ID: 22377215), but there is no evidence of clinical development or approved therapeutic use. Its mechanism of action and biological targets have not been described in public sources. The compound's primary relevance appears to be as a research tool or chemical probe rather than as a developed pharmaceutical agent[1][2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 4-({[4-(3-methylbenzoyl)pyridin-2-yl]amino}methyl)benzenecarboximidamide.